Naqvi Syed Jawad Haider, Voppuru Saiesh Reddy, Wigle Dennis
Department of Thoracic Surgery, Mayo Clinic, Rochester, MN, USA.
AME Case Rep. 2024 Mar 25;8:50. doi: 10.21037/acr-23-178. eCollection 2024.
Intrabdominal hematoma can be managed with angioembolization, surgical drainage, or percutaneous drainage depending on the patient factors, underlying pathology, and size and stability of hematoma. During the past decades, advancements have been made in the percutaneous management of intrapleural fluid collections using fibrinolytics. However, intrabdominal hematoma resolution with the help of fibrinolytic-assisted percutaneous drainage has not been as widely studied as intrapleural fibrinolytics. Our case presents a scenario where effective percutaneous drainage of abdominal fluid collection using fibrinolytics avoided an operative intervention in a patient with a history of multiple abdominal surgeries. This case report in essence can help navigate future studies into exploring non-operative management options in patients with a history of multiple abdominal surgeries.
In this report, we present a 51-year-old female status post hiatal hernia repair with jejunostomy tube (J-tube) exchange complicated by walled off intraabdominal hematoma who presented with persistent abdominal pain and leakage around her J-tube. Due to her past history of multiple abdominal surgeries including multiple hiatal hernia repairs, distal esophagectomy with Roux-en-Y, and revision of the said Roux-en-Y complicated by wound dehiscence, surgical drainage was deferred in favor of trialing fibrinolytic administration via catheters. For this purpose, we employed the protocol for fibrinolytic administration used by the Second Multicenter Intrapleural Sepsis Trial (MIST2).
Use of tissue plasminogen activator (t-PA) and deoxyribonuclease (DNase) as per MIST2 protocol was safely replicated for intrabdominal walled off hematoma and resulted in a near complete resolution of the hematoma in 1 week. The patient was eventually discharged with no complications. This case highlights safe and efficacious use of fibrinolytics for non-operative management of intrabdominal hematomas.
根据患者因素、潜在病理情况以及血肿的大小和稳定性,腹腔内血肿可通过血管栓塞、手术引流或经皮引流进行处理。在过去几十年中,使用纤维蛋白溶解剂对胸腔内积液进行经皮处理已取得进展。然而,借助纤维蛋白溶解剂辅助经皮引流来解决腹腔内血肿的研究不如胸腔内纤维蛋白溶解剂广泛。我们的病例展示了一种情况,即使用纤维蛋白溶解剂对腹腔积液进行有效的经皮引流,避免了对有多次腹部手术史的患者进行手术干预。本病例报告本质上有助于指导未来对有多次腹部手术史患者探索非手术管理方案的研究。
在本报告中,我们介绍了一名51岁女性,她在食管裂孔疝修补术后更换空肠造口管(J管)时并发包裹性腹腔内血肿,出现持续性腹痛和J管周围渗漏。由于她过去有多次腹部手术史,包括多次食管裂孔疝修补术、远端食管切除术加Roux-en-Y吻合术以及上述Roux-en-Y吻合术因伤口裂开而进行的修复术,因此推迟了手术引流,转而尝试通过导管给予纤维蛋白溶解剂。为此,我们采用了第二次多中心胸腔内脓毒症试验(MIST2)使用的纤维蛋白溶解剂给药方案。
按照MIST2方案使用组织型纤溶酶原激活剂(t-PA)和脱氧核糖核酸酶(DNase)对腹腔内包裹性血肿进行处理是安全可行的,1周内血肿几乎完全消退。患者最终出院,无并发症。本病例突出了纤维蛋白溶解剂在腹腔内血肿非手术管理中的安全有效应用。